Moreover, in vivo immune-virotherapy with stains of measles virus (MV) in combination with anti-PD-L1 blockade synergistically enhanced the infiltration of activated CD8+ T cells within the TME and increased the survival of the syngeneic GBM mouse model (240). This evidence concerns the gene CD8A and glioblastoma.